Skip to main content
. 2021 Sep 20;9(9):1272. doi: 10.3390/biomedicines9091272

Figure 1.

Figure 1

The complete workflow of the current study. A first discovery phase by Next-Generation Sequencing (NGS) included a cohort of 7 DLB patients and 7 healthy controls. Selected miRNAs were validated in three independent qPCR validation studies.